C62.0 (Malignant neoplasm of undescended testis) compared with D07.69 (Carcinoma in situ of other male genital organs), from the official CMS tabular data. C62.0 and D07.69 name the same anatomical site (testis) with a different neoplasm behavior. MedCoder-derived
Same anatomical site, different neoplasm behavior.
Same site — carcinoma in situ (testis)
The behavior documented for the site — malignant primary, secondary, carcinoma in situ, benign, uncertain or unspecified — decides which column of the neoplasm table, and therefore which code, applies.
Source: CMS Table of Neoplasms
Same site, different neoplasm behavior. C62.0 and D07.69 name the same anatomical site (testis) with a different neoplasm behavior.
From the CMS/CDC Table of Neoplasms: the behavior documented for that site — malignant primary, secondary, carcinoma in situ, benign, uncertain or unspecified — decides which column, and therefore which code, applies.
| C62.0Malignant neoplasm of undescended testis | D07.69Carcinoma in situ of other male genital organs | |
|---|---|---|
| Billing status | Non-billable header | Billable |
| Classification | C00-D49 — Neoplasms (C00-D49) | C00-D49 — Neoplasms (C00-D49) |
| Definition | Malignant neoplasm of undescended testis is a non-billable ICD-10-CM category code (C62.0). | Carcinoma in situ of other male genital organs is a billable ICD-10-CM diagnosis code (D07.69). |
| Includes | malignant neoplasm of skin of male genital organs Malignant neoplasm of ectopic testis Malignant neoplasm of retained testis | Bowen's disease erythroplasia grade III intraepithelial neoplasia Queyrat's erythroplasia |
| Use additional code | code to identify any functional activity | — |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources